Artal Group’s ContraFect Corporation CFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-18,750
Closed -$34K 142
2023
Q1
$34K Hold
18,750
﹤0.01% 118
2022
Q4
$144K Hold
18,750
0.01% 127
2022
Q3
$252K Hold
18,750
0.01% 132
2022
Q2
$4.61M Hold
18,750
0.25% 61
2022
Q1
$5.47M Hold
18,750
0.23% 73
2021
Q4
$3.94M Hold
18,750
0.11% 112
2021
Q3
$6.08M Hold
18,750
0.14% 107
2021
Q2
$6.6M Hold
18,750
0.13% 112
2021
Q1
$7.2M Buy
18,750
+6,250
+50% +$2.7M 0.13% 115
2020
Q4
$5.05M Buy
+12,500
New +$5.41M 0.11% 107

Other funds holding CFRX

Artal Group's CFRX Position: Q2 2023 in Review

Artal Group sold out of ContraFect Corporation (CFRX) in Q2 2023, closing a stake of 18,750 shares — an estimated $34K sold.

Artal Group first reported a position in CFRX in Q4 2020 and held it in 10 quarters. The position peaked at $7.2M in Q1 2021. 16 funds tracked by Wall St. Rank hold CFRX as of Q2 2023.

  • Artal Group reported no remaining ContraFect Corporation position as of Q2 2023 after selling out during the quarter.
  • Artal Group sold 18,750 ContraFect Corporation shares in Q2 2023, an estimated $34K.
  • Artal Group first reported a position in ContraFect Corporation in Q4 2020 and held it in 10 quarters.
  • Artal Group's ContraFect Corporation position peaked at $7.2M in Q1 2021.
  • 16 funds tracked by Wall St. Rank held ContraFect Corporation as of Q2 2023.

Based on Artal Group's 13F filing for Q2 2023, filed 11 Aug 2023.